Results 201 to 210 of about 1,151,634 (240)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Editorial: Diagnostic and treatment strategies for periodontal disease. [PDF]

open access: yesFront Dent Med
Janakiram C   +3 more
europepmc   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte   +13 more
wiley   +1 more source

Advances in Microbial Diagnostics: Machine Learning and Nanotechnology for Zoonotic Disease Control. [PDF]

open access: yesWiley Interdiscip Rev Nanomed Nanobiotechnol
Lotfalizadeh N   +8 more
europepmc   +1 more source

EndoCompass Project: Endocrine Laboratory Medicine.

open access: yesHorm Res Paediatr
Heijboer AC   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy